The Latest Breaking News from Medical – Pharmaceuticals

The No. 1 Stock to Buy on a Panic Sell-Off

The Fed’s hawkish stance to control stubborn inflation has led to a massive sell-off in the stock market this year. Amid this backdrop, we think drug maker Johnson & Johnson (JNJ) could be an ideal buy because of its solid fundamentals and reliable dividends. Read on….

StockNews.com · Oct 20, 2022

This Pharmaceutical Stock Is Still a Smart Buy in 2022

Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail….

StockNews.com · Oct 19, 2022

1 Medical Stock That's a Better Buy Than Its Peers

Healthcare giant (MRK) has gained more than 20% in 2022. Moreover, it pays handsome dividends to its shareholders. And its attractive valuations and robust profitability make it a better Buy than its peers. Let's discuss this in detail….

StockNews.com · Oct 17, 2022

1 Stock You'll Wish You Bought Sooner

Amid the highly uncertain market conditions, investors must look for stocks with ample room for growth and better stability. Biopharmaceutical major Pfizer’s (PFE) products remain in demand irrespective of economic cycles. Given its robust financials, discounted valuation, and high profitability, it could be wise to invest in this defensive stock.…

StockNews.com · Sep 16, 2022

3 Safe Investments for Seniors to Consider Right Now

August CPI figures indicate that inflation is yet to be controlled, and the Fed might launch another significant interest rate hike next week. As recessionary fears loom over the economy, it might be ideal for seniors to invest in the fundamentally sound stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and…

StockNews.com · Sep 16, 2022

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

StockNews.com · Sep 13, 2022

3 Cannabis Stocks Going up in Flames to Avoid

The wide use of cannabis for recreational activities and its increased medicinal use has helped the market gain traction over the past years. However, with legalization barriers worldwide, this industry is in an odd limbo in which consumption flourishes, but penalties and taxes still prevail. Given the backdrop, it should…

StockNews.com · Aug 30, 2022

Should You Follow the Insider Buying in Summit Therapeutics

Shares of the biopharmaceutical company Summit Therapeutics (SMMT) gained over the past few days, driven by significant insider buying. However, as the stock is down more than 55% this year, would it be wise to invest in the stock now? Read on to find out….

StockNews.com · Aug 26, 2022

Is Pfizer a Buy Before New Omicron Boosters Roll Out?

Pharmaceutical giant Pfizer’s (PFE) omicron-targeted booster doses could soon be authorized this fall. The company has benefited largely from the pandemic and its vaccine rollouts. Now let’s find out if PFE is a Buy now as it prepares to roll out its booster doses….

StockNews.com · Aug 26, 2022

Better Buy: Axsome Therapeutics vs. Johnson & Johnson

Axsome Therapeutics (AXSM) and Johnson & Johnson (JNJ) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the pharmaceutical sector. But which of these stocks is a better buy now? Read more to find out….

StockNews.com · Aug 24, 2022